|
|
Other links at Articles > Cardiology |
| 3. |
FDA Safety Changes: Gleevec, Keppra, Neupogen
|
|
|
The FDA has approved revisions to the safety labeling for imatinib mesylate tablets (Gleevec), levetiracetam injection (Keppra), and filgrastim injection (Neupogen). Medscape Medical News
|
| 5. |
Three Common SNPs Strongly Associated With DVT
|
|
|
Researchers in the Netherlands have identified three SNPs that appear to increase the risk of DVT. Although the effects of each SNP are modest, they occur commonly so could be responsible for many thrombotic events, they note. Further work is needed to understand the implications of the findings, they add. Heartwire
|
|
|
